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·relating to the distribution of veterinary medicines 
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By letter of 9 January 1980, the Committee on Agriculture requested 
authorization·to draw up a report on the approximation of the laws of the 
Member States relating to the distribution of veterinary medicines. 
At its sitting of 13 October 1980, the European Parliament authorized 
the Committee on Agriculture to report on this subject. The Legal Affairs 
Committee and the Committee on the Environment, Public Health and Consumer 
Protection were asked for opinions. 
On 20 October 19~0, the Committee on Agriculture appointed Mr Brian Hord 
rapporteur. 
At its meetings of 1 December 1983 and 2 February 1984, the Committee 
on Agriculture considered the draft report. It adopted the motion for a 
resolution as a whole on ~ February 1984 by 23 votes to 1 with no abstentions. 
-- --- -- ----------
-----
The following took part in the vote: Mr Curry, chairman; Mr Fruh, 
Mr Colleselli and Mr Delatte, vice-chairmen; Mr Hord, rapporteur; Mr Abens 
' (deputizing for Mrs Castle>, Mr Barbagli (deputizing for Mr Clinton>, 
Mr Battersby, Mr Dalsass, Mrs Desouches <deputizing for Mr Gatto), Mr Eyraud, 
Mr Gautier, Mr Goerens <deputizing for Mr Maher>, Mr Helms, Mr Kirk, 
Mr Maffre-Bauge, Mr Marck, Mr Mertens, Mr Provan, Mr Stella (deputizing for 
Mr Diana), Mr Sutra, Mr J. D. Taylor (deputizing for Mr Simmonds>, Mr Tolman 
and Mr Woltjer. 
The present report was tabled on~ February 1984. 
0 
0 0 
The opinions of the Legal Affairs Committee and the Committee on the 
Environment, Public Health and Consumer Protection are attached. 
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The Committee on Agriculture hereby submits to the European Parliament 
the following motion for a resolution together with explanatory statement: 
A 
11.9JJ..91t!..91t}_~s~..9!-.YJJ..9N 
on the approximation of the laws of the Member States relating to the 
distribution of veterinary medicines 
Th_e European Parliament, 
- having regard to the report of the Committee on Agriculture and the 
o):>inions of the Lega'L Affairs Committee and the ·committee on the 
Environment~ Publii Health and Consumer Protection (Doc.1-1409/83), 
(a) having regard to two Directives on the approximation of the laws of 
Member States relating to veterinary medicinal products and to 
analytical pharmaco-toxicological and clinical standards and protocols,1 
(b) having regard to the entry into force on 18 December 1981 of the 
Directive 78/1016 concerning the right of establishment, which will 
allow veterinary surgeons the right to establish themselves in EEC 
countries other than their country of origin, 
<c> having .regard to the setting up of an Advisory Committee on veterinary 
training and a Scientific Veterinary Committee, 
(d) whereas veterinary and animal health products constitute one of the 
principal means by which the dramatic advance in agricultural productivity 
in the past decades has been possible, 
1. Emphasises that veterinary medicines are of major importance to the 
economic performance and welfare of the Community's livestock population, 
and constitute one of the principal elements of prophylatic and eradication 
measures; 
2. Stresses, furthermore, that veterinary medicines are of major importance 
to public health, in particular in view of the creation of unacceptable 
residue levels and transferable drug resistance in man; 
3. Notes that differences in rules applied by Member States result in 
differing costs to producers, profit margin and prices for food and 
livestock; 
----------------
1 OJ No L 317, 6.11.81, p.1 and 16 
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4. Points out that the directives adopted by the Council concerning 
veterinary medicinal products and analytical, pharmaco-toxicological 
and clinical standards and protocols will not be able to achieve their 
essential objectives in the absence of an adequate regulation of the 
distribution and use of veterinary medicinal products; 
5. Considers that measures for the control of the distribution and use of 
veterinary medicines should begin with a classification of those products 
according to their degree of toxicity and the residue level~ in foodstuffs 
of animal origin <milk and meat in particular)and thus to be distributed 
<a> by prescription only 
<b> by pharmacist, veterinary sur~eon or licensed retailer only 
(c) by pharmacist or animal health products retailer 
(d) by general sale; 
6. Considers that the conditions of sale of veterinary products should be 
determined on the basis of the classification provided for in paragraph 5; 
7. Accepts that there exists a range of mass-use prophylactics, routine 
treatments and applications which are safe for general sale 
and supply to farmers; further, that the general sale of these is a 
determining factor in the competitiveness of livestock farming; 
8. Considers that the sale of medicinal products other than those on general 
sale should be by prescription from a veterinarian only; the seller -
pharmacist, veterinary assistant, technician employed by a cooperative 
or producer group - should be required to authenticate the signature of the 
veterinarian and the geographical area for which he is responsible; 
9. Considers, however, that the supplementing of animal feedingstuffs with 
medicinal products should be avoided as far as possible; 
10. Notes that a proper balance, based on scientific criteria, should be 
made between each list, in order to avoid encouraging the development 
of a black market in certain products, as well as a cumbersome 
bureaucratic structure; 
11. Points out that any unnecessary restriction in supplies of veterinary 
products could lead to an increase in their costs which may, through 
a reduction in use, affect the health of the Community's livestock; 
Notes, at the same time, that costs of these products by out let var}r.: 
considerably from country to country; 
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12. Considers that the Member States should agree on common regulations and 
standards for determining and quantifying the residues of medicinal 
products in foodstuffs of animal origin; 
13. Insists on the need to harmonize the.recruitment and qualifications of 
abbatoir inspectors in the Member States by bringing Community 
legislation into line with that of the Member State with the most 
stringent requirements; 
14. Stresses the importance of effective control measures and adequate 
sanctions in order to ensure respect for measures adopted; 
15. Instructs its President to forward this resolution and the report 
of its Committee to the Council and Commission of the European 
Communitie'S. 
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er:QE2Q!2LfQ.L!-~QYD£i! __ (ti_r_~c;_ti_'!.~-q.!'Lth_~-~.P.!..<t'ti"!.cttict'l_ctt_tll.~J .. ~t_ctt 
M!m~!r-~!!1!!_r!!21ing_!Q_!h!_9i!1ri~Y!i2n_Qf_y!!!rin2r~-m!9i~in!! 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European Economic Community, 
and in particular Article 100 thereof, 
Having regard to the proposal from the Commission, 
Having regard to the opinion of the European Parliament, 
Having regard to the opinion of the Economic and Social Committee, 
Having regard to the proposal for a directive, 
Whereas the proposed directives on the standard of veterinary medicines 
will be ineffective in the absence of measures concerning the distribution 
of such medicines; 
Whereas the primary purpose of any rules for the production and distribution 
of veterinary medicinal products must be the safeguarding of public health; 
Whereas, however, this objective must be achieved by means which will not 
hinder the development of industry and trade in medicinal products within 
the Community; 
Whereas distribution of veterinary medicinal products within the Community 
is hindered by disparities between certain national provisions, in particular 
between provisions relating to the controls on distribution and sale and such 
disparities directly affect the establishment ~nd functioning of the'Common 
Market. 
HAS ADOPTED THIS DIRECTIVE: 
CHAPTER I 
Q!fini!i2n!_!n9_!£2e!_Qf_!ee!i£!1i2n 
For the purpose of this Directive, the following definitions shall apply: 
- Y!1!!iD!!~_!I!!9i~iO!!_er29Y~! shall mean any medicinal product intended 
for animals; 
- 2Di!l!!! includes any mammal, bird. or fish; 
- !Di!l!!i!_YQQ!£_£!£!_Qf_!-Y!!!!iO!!i!O means those animals which he sees 
from time to time or those specially examined for the purpose of diagnosis 
and treatment; 
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(i) a person duly qualified and licensed or registered to practice 
pharmacy; or 
(ii> persons experienced in the sale of veterinary medicinal products 
liste~ or recognized as such by a Member State. g!e!ri!D~!Q means 
a person with at least five years practical veterinary product sales 
experience, or one who has completed a course of tuition recognized 
by one or more Member State governments on veterinary medicinal 
products and their proper use; 
- ~!!!rio!ri!O means a person duly qualified and licensed or registered to 
practice veterinary surgery and medicine. 
All veterinary medicinal products shall be placed in one of four lists 
according to method of re~~il supply being: 
(a) prescription only 
(b) by pharmacist, veterinary surgeon or licensed retailer only 
(c) by a pharmacist or animal health products retailer 
(d) for general sale 
Prescription only products may be supplied or sold only by a veterinarian 
to persons owning or responsible for animals under his care for such animals. 
Veterinarians should prescribe prescription only products and such prescrip-
tions may be dispensed and supplied by pharmacists. 
ar!i~!!_~ 
Pharmacy products may only be sold or supplied by registered pharmacies 
or by veterinarians to persons owning or responsible for animals under 
their care. In addition products in category 2(d) may be sold by animal 
health retailers from listed premises. 
General sale list products may be sold by anyone provided the sale is made 
in unopened and original packages. 
Article 6 
A Veterinary Products Committee composed of representatives of all _the 
Member States will keep the lists and classifications of veterina~y medicinal 
products under review. Before ·ma.king any alteration, addition or deletion 
to the lists, the Committee shall consult the Veterinary Associations, 
commercial organizations dealing with veterinary medicinal products and 
Pharmaceutical Societies of the Member States. 
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~!:!A~!s!L!U 
!n!e!£!i2n£_1!e!!!ing_!n9_e!£!!9ing 
All premises of animal health products retailers must comply with accepted 
standards of hygiene and be inspected at regular intervals by the authorities 
of the Member States. 
Premises shall provide adequate and suitable storage facilities to permit 
the storage of veterinary medicinal products in accordance with accepted 
standards or the manufacturers' recommendations. 
ArU£1!-~ 
The provisions of Chapter VII, Article 43, of Council Directive 81/851/EEC 
of 28 September 1981 shall apply. 
Packaging shall be adequate and suitable and sufficiently impervious to 
withstand accidental contamination. No general sale list trader may break 
or open bulk packages. 
~!:!aenB_l~ 
§Ye!r~i!i2n_tog_!!D,1i2D! 
Adequate records of purchases and sal~s shall be kept in respect of trade 
in veterinary medicinal products. 
The competent authority of the Member State concerned shall ensure by 
means of inspection, that the legal requirements relating to the distribu-
tion of veterinary medicinal products are complied with. 
Such inspections shall be carried out by officials representing the competent 
authority who shall be empowered to: 
1. inspect commercial establishments; 
2. take samples; 
3. examine any documents relating to the object of the inspection. 
The competent authorities of the Member States shall suspend or withdraw 
authorization to distribute veterinary medicinal products when it is clear 
that: 
1. the obligations referred to in the Directive have not been fulfilled; 
2. the information given in the dossier pursuant to Article 11 is incorrect. 
- 10 - PE 74.398/fin. 
Member States shall put into force the measures needed in order to comply 
with the Directive within eighteen months of its notification and shall 
inform the Commission. They will also inform the Commission of the main 
provisions of the National law which they adopt to conform with the 
Directive. 
This Directive is addressed to the Member States. 
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8 
~~~~~~~I~[!-~I~I~~~~I 
The role of veterinary medicine in the CAP 
The main aims of the Common Agricultural Policy are to improve the 
efficiency of farming, and freedom of movement of goods throughout the 
Community. Some of the more technical areas, such as veterinary medicine, 
may be overlooked but they make an extremely valuable contribution to these 
aims. 
The health of livestock is important to farmers• incomes; the economics 
of modern livestock production are influenced through the elimination of 
certain types of animal diseases. 
The importance of animal health and veterinary medicines has become of 
increasing importance both to the farmer and to the consumer in the process 
of the modernization of production technology. Veterinary and animal health 
products constitute one of the main arms by which the dramatic advances in 
productivity over the past few decades has been made possible. Veterinary 
medicines are important to the welfare of the individual animal, improving 
its performance as well as reducing suffering. They are also important to 
the welfare of the Community's herds and flocks as a whole, constituting 
the principal element of prophylatic and eradication measures. 
Veterinary medicines also raise the equally important issue of public 
health. It is obvious that the elimination of diseases which can be trans-
mitted to humans has a beneficial effect for the consumer. But this type 
of consumer protection must extend to the entire production chain to prevent 
many pathogenic micro organisms and toxic or otherwise harmful substances 
used in farming being passed on in foodstuffs. Significant dangers exist if 
medicines are used incorrectly, and in particular to the health of the 
consumer from unacceptable residue levels. It is also possible that 
transferable drug resistance can be created in man. For example, it is 
generally recognized that the widespread use of chloramphenicol in foQd 
producing animals may build up resistance to a drug vital for the treatment 
of salmonellosis (e.g. typhoid). 
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A further problem arises from differences in rules applied by Member 
States resulting in differing costs to producers, profit margins, and prices 
at which livestock and foodstuffs of animal origin can be offered for sale 
throughout the Community. To the extent that the costs of maintaining stock 
healthy vary from country to country, this brings about differences in costs 
of production, so undermining free competition. 
The necessity for measures to regulate veterinarY medicines 
It is clear therefore that the Community must seek to ensure common 
. . 
standards of safety for veterinary medicines used throughout the Community. 
To this end, the Council adopted two directives in November 1981, one on 
the approximation of laws of the Member States relating to veterinary 
medicinal products 1, ar.d the other on the •pproximation of laws relating to 
analytical~ pharmo-toxieotogi·cal and" clinicaCs'tam:tlr~~ f'r6tot"ols for 
the testing of veterinary medicinal products2• The Commission .. 
has extended the scope of these measures by a directive on the manufacture 
putting into circulation and supply of medicated feeding-stuffs in the 
Couunity. 3 
It it is true that it is unsafe in terms of the welfare of the public 
and livestock for the use of veterinary medicines to remain uncontrolled, 
it follows logically that the' distr·ibution of such medicines cannot remain 
unregulated. Without proper control of sales there can be no adequate 
guarantee for the final destination of thes•·Prpdu~ts. 
Therefore, while taking note of the fact that the Council has adopted 
two draft directives on veterinary products and stlndards, a further 
directive on their distribution is required. 
1 
Directive 81/851/EEC, OJ L317, 6 Nov, 1981, p.1 
2 
Directive 81/852/EEC, OJ L317, 6 Nov, 1981, p.16 
3 
The Europeae~.;Parliament approved this measure OJ C128 of 16.5.83, p.76 
, 
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-~----·· --------~----· ___ .. .,.--· --· 
. -· . - . ' - ~- .... -· - ·- -
Deciding on the proaer approach to regulating the sale of vetedna,rx-pdi.cinss 
The ·arguments laid out above carry cOnsiderable weight but as in most· 
areas a proper balance must be sought. 
It is possible that increased legislation will lead to higher costs; 
and the cost of production for the sake of the producers and the consumers 
should not be increased unnecessarily as a matter of principal. 
horeover, it is probable that if costs were to be increased considerably 
any legislation would be self:defeating as use of essential medicines 
decreased creating even greater dnagers for the animals and public. 
Any proposal tor regulation of distribution of veterinary medicines 
therefore should examine conscientiously the arguments for sufficient 
flexibility, as well as for greater restrictions in distribution. 
We should be aware, furthermore, that· subs.t.antial financial issues 
are at stake. Veterinary medicines are high volume products, whose sales 
I 
are of considerable value to the outlets in rural areas~ In countries 
where more than one outlet is permitted, conflicts of interest exist 
between the pharmacies, the veterinariaris an~ the merchants/cooperatives. 
The merchants and cooperatives seek a degree of flexibility in the 
sale or supply of products. 
The veterinarians, on the ·other hand, believe they should be more 
largely responsible, and that agricultural merchants are unsuitable 
outlets for veterinary medicines unless their medicine sales are carried 
out under the same conditions as a pharmacy. 
Arguments for greater flexibility 
(i) UK farm input costs of animal aedicines is estimated by the traders 
at between £65-70 million. per. annum. Merchants argue that greater 
restriction in distribution could increase costs in some countries by up 
to 30%. Any reduction in use resulting f'rom increased cost would 
affect the future health of livestock and the public. It is 
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probable that an incrHse in eos.t-s woutd · crf'at• a btack Rr.ket 
of less strictly controlled products used increasingly by less 
knowledgeable people. 
At the same time; less use might be made of veterinary medicines 
and veterinary products leading·to deterioration in . 
the health of the Community liv,stock population, and even the 
resurgence of diseases which are at pr~sent ~der control. 
<ii> Apart from increasing costs, the traders argue that restrictions: 
<a> retard the proper development of these medicines 
(b) produce an undesirable professional bureaucracy 
For these reasons the traders seek to make a clear distinction between: 
- veterinary. products designed for use by the veterinary surgeon 
(approx. 10% of production); and 
. 
- animal health products designed to be sold by retail to the farmer 
(90% of production). 
Arguments for greater restrictions 
The pharmacists have a Aumber of reasons for imposing tight restrictions 
on sales: 
As with many medicines, serious hazards may be created for the health of 
the animal, and for public health through transference of antibiotic 
residues, as a result of incorrect use oj medicines.,~sed by unqualified 
persons; 
Toxic properties of medicines cannot be properly judged by unqualified 
persons and therefore these products should not ·be made freely available 
to the public; 
' 
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•. 
Storage and shelf life is vital to safe and effective use of medicines, 
and this may not be respected by traders, who are not trained to realize 
the particular dangers of these products; 
Veterinary surgeons can give comprehensive advice which is not in the 
posession of the trader, and can ensure that the drugs are used properly 
and only where necessary. This may lead to savings for the farmer. 
Legislation in the Member State! 
Clearly, we a~e dealing here with a multit~de of products which 
can range from innocuous treatments for improving animal performance to 
complex medicines which in the unpracticed hand may produce dangerous 
toxic results for the animal and the consumer. These differences between 
products is reflected in the legislation of certain Member States. 
In the United Kingdom and France, categories have been created 
according to whether the products may be sold by pharmacists, veterinarians 
or merchants and cooperatives. In other countries, the sales are in the 
hands of the pharmacists or the veterinarians. Only in Ireland a free 
for all situation exists. 
The situation may be summarized as follows: 
France: 
Germany: 
In the past, veterinarians sold a great majority of 
medicines, while cooperatives were allowed to sell 
certain innocuous medicines and animal health 
products they had sold traditionally. New legis-
lation is intended to restrict cooperatives/merchants 
to a shorter list while the French pharmacy sector 
has campaigned to restrict all products not currently 
sold on prescription to the pharmacy only. 
90% of distribution under veterinary control and 10% 
by pharmacists. 
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Italy: Pharmacists have a monopoly of supply and veterinary 
surgeons may hold emergency stocks. 
-. 
Belgium/Luxembourg: Sales are under the control of pharmacists from whom 





All distribution whether by prescription or sale is 
in the hands of the veterinary profession. 
Veterinary surgeons must purchase from a pharmacy and 
farmers have to obtain their supplies on prescription. 
The situation is as in the list system proposed on 
page 18. 
Veterinarians, pharmacists and cooperatives all compete 
for sales of all types of products 
It has been calculated that for the Community as a whole distribution 








It has also been calculated that a black market has developed as 




20% to 30% 
90% 
30% to 40% 
\. 1.,. 
- 17 - PE 74.398/fin. 
Creation of a list system 
Given the differences in the present distribution of animal health 
products throughout the Community, future legislation is likely to be the 
result of a compromise between those countries adopting a flexible 
position and those with a very strict regulation of sales. A compromise 
is likely to take the form of a list of categories under which products 
will be classified according to permitted types of outlet. 
The categories are 
er!!£rie!iQo_Qo!x_~!9ifiD!!_£eQ~l 
Medicines which must be administered or prescribed 
by doctors and veterinarians; they and pharmacies 
may carry stocks • 
en~rm~£x_Qo!x_£el 
A relatively short list of products restricted to sale 
by pharmacies. May be stocked as above. 
Innocuous medicines that can be sold by any retailer. 
These are animal health products which ought to be 
classified as POM but, because agricultural merchants, 
cooperatives etc., have sold them traditionally, they 
can continue to be sold by merchants for a temporary 
period that has yet to be specified. 
As PML products comprise the major market value and volume of all AHPs 
sold, there is conflict about which categories will be allocated to PML 
products once the 'temporary period' ends. 






















DENMARK - PRODUCERS' VETERINARY COSTS 1975/76 - 1979/80 
DAIRY COWS SOWS AND BACONERS SOWS AND WEANERS 
106 144 104 
114 151 108 0.33 
136 160 112 0.23 
161 165 117 0.14 
175 '~ 0.13 
OTHER COSTS 1979/80 
10,206 10,594 4,631 99.01 
3,250 6,608 2,553 76.55 
100 59 59 2.17 
583 857 336 3.62 




















Value Volume 1980 Price Value 
-----------------------------12§Q _________ !o~!~-----~1-12Z~_eri£!! __________ !o~!~-----------------12~1-----
Animal feed 28,151 104 29,277 114 33,376 
Fertilizer 18,027 99 17,847 111 19,810 
Oil products 5,005 99 4,955 128 6,342 
Plant protection products 7,589 109 8,272 109 9,016 
Maintenance of buildings 2,772 102 2,827 113 3,195 
0 
Equipment repairs 8,182 101 8,264 115 9,504 N 
Veterinary expenses 3,930 104 4,087 113 4,618 
Other goods 8,700 103 8,961 111 9,947 
Q!h!£_!!£~i£!!--------------~L§~~-----------1Q~----------~L2~~---------------11~------------------~L~r~----
TOTAL 86,199 102.6 88,448 113.4 100,281 
-----------------------------------------------------------------------------------------------------------
of the 
Legal Affairs Committee 
Draftsman: Mr MEGAHY 
At its meeting on 28 October 1980, the committee appointed 
Mr Meg~hy draftsman. 
The committee considered the draft opinion at its meeting of 
25 and 26 January 1984 and adopted it by 8 votes to 1. 
The following were present at the vote ; Mr LUSTER, vice-chairman 
and acting chairmtn; Mr MEGAHY, draftsman; Mr DEL DUCA, Mr GEURTSEN,. 
Mrs love NIELSE~, Mr PROUT, Mr SIEGLERSCHMIDT, Mr TYRRELL,Mrs VAYSSADE 
and Mr VETTER. 
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1. By letter of 26 September 1980, the Enlarged Bureau requested the 
Legal Affairs Committee to draw up an opinion o~ the own-initiative report 
which the Committee on Agriculture had been authorized to draw up concerning 
veterjnar~ medicinal products. 
2. The subject of the present opinion is the draft report drawn up 
by Mr Hord (PE 74.398> which proposes certain measures for the control 
of the distribution and the use of veterinary medicinal products, on the 
basis of a tripartite classification of these products according to the 
retail outlets from which they should be obtained. Apart from the draft 
motion for a resolution, the draft report also contains a"proposal for 
a Council Directive on the approximation of the la~s of the ~-mber 
States relating to the distribution of veterinary medieines~· 2 ~ich is 
presumably intended to give effect to the committee's proposals, though, 
strangely, no mention is made of this "proposed directive" either in the 
draft motion for a resolution or in the explanatory statement attached 
thereto. 
3. The basic provisions of Commu.nity law on proprietary medicinal 
products were laid down in Council Directive 65/65/EEC of 26 January 
1965~ "Medicinal product" is defined in Article 1<2> of this Directive 
to include "any substance or combination of substances presented for 
treating or preventing of disease in human beings or animals", though 
the substantive provisions of the Directive were expressly restricted to 
proprietary medicinal products for human use by Article 2. The Directive 
sets out a system of authorization by the competent authority of the 
Member States to place a proprietary medicinal product on the market, 
and lays down the particulars which must accompany an application for 
authorization. 
1 At its meeting of 25 and 26 January 1984, the Committee was only able 
to examine the text of this proposal in the original language, English~ 
"·rhe term "medicinal products" rather than "medicines" is employed in the 
relevant Community legislation ~nd is used throughout this opinion. 
3' OJ No. 22, 9 February 1965, page 369/65. 
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4. Two Council Direct~ves of 20 May 197~ extend Directive 65/65/EEC; 
Directive 75/319/EEC sets ~o a Committee for Proprietary Medicinal Products 
which can give the requisi~e authorization where the applicant already in 
possession of one marketin~ authorization wishes to market the same product 
in at Least five other Memt~r States, while Directive 75/318/EEC. lays down 
in some detail the testing requirements for these products. A further 
Council Directive of 26 Octcber 19832extends the earlier provisions to 
facilitate the tree moveme~: of proprietary medicinal products for 
human use by allowing the Cc~mittee for Ptoprietary Medical Products to 
give an authorization for marketing in at least two MemberStates and by 
obliging the competent authorities of a Member State which is examining 
an application to give "due consideration" to any earlier authorization 
granted to the same applica~t in respect of the same product. 
5. For veterinary medicinal products, two Council Directives of 
28 September 19813set up a marketing authorization system similar to that 
then in force for medicinal products for human use adaptedto the partic-
ularities of the veterinary sector, e.g., the broader rang~ of medicaments~ the 
problem of noxious residues in animals destined for human consumption and 
the increased costs in testing products for such residues, the limitation 
in the use of certain medicinal products such as antibiotics and hormones 
and the flourishing black market in veterinary medicinal products in 
Member States where the control of their distribution is strictest. As 
with the legislative provisions on proprietary medicinal products for 
human use, these directives attempt to balance the require•ents of the 
protection of public health with those of the free movement of goods, the 
latter including not only pharmaceutical products but also animals and 
animal producti within the territory of the Community. 
i 
i 
6. Your draftsman drew to the committee's attention that,·~t .• lithout prejudice .\ 
I 
to the merits or demerits of the distribution scheme prooosed by the Committee 
on Agriculture, there are a number of factors which couldpilitate against 
the proposing of such a draft Council Directive in the report of a parlia-
mentary committee. In its resolution of 9 July 1981 on the right of 
1
oJ L 147, 9 June 1975, pages 1 and 13. 
2oJ L 332, 28 November 1983, page 1: Directive 83/570/EEC. 
3oJ L 317, 6 November 1981, pages 1 and 16: Directives Nos. 81/851/EEC and 
81/852/EEC. 
4see "L'harmonization des legislations concernant les medicaments 
veterinaires", 1982 R.M.C., page 156. 
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Legislative initiative and on the role of the Euro~ean Parliament in 
the Legislative process of the Community1, the European Parlia~ent 
con!lidereo thi:lt it shoulG "oevelop further its right to make 
er2QQ~2l~_£QQ£~toios_~Q@8YDi!~-QQli£~ through resolutions requesting 
the Commission to introduce legislative proposals"; the Parliament did not 
assert any right to propose legislation in its quasi-definitive form, for 
reasons which were outlined very clearly in the opinio~submitted to the 
Political Affairs Committee by the Legal Affairs Committee on the subject: 
"The exercise of legislative initiative necessitates a formidable 
amount of technical means and data. That is all the more true 
at European level, there account must be taken of existing laws 
in ten different Member States. The institution that, in the 
Community, disposes of the appropriate means is the Commission. Of 
course, the European Parliament can continue to give political guide-
lines to the Commission, over which it has control, for tabling 
such drafts as it thinks should be proposed; iD-~~£~eSiQ02l_£2~~§, 
these guidelines can go as far as an articulated proposal (that has 
been done in the past: for example, the proposal - Doe. 340/73 -
on the European Cooperation Grouping which the Commission tabled 
after Messrs. Armengaud and Jozeau-Marigne had presented -
9 August 1971 - a motion for a resolution embodying a draft 
regulation>". 
7. A further, legal, difficulty coul~ arise from the wording of Article 100 
of the EEC Treaty, which is proposed as a legal basis for this Directive; 
this obliges the Council to issue directives "acting unanimously on a 
proposaljrgn_~bf.f.f'l'!li.§.§iql~'. Thus, for a proposal emanating fran .the P~_rl iament to be ad::.l:lted by 
the Council, it would need to be taken over in its entirety by the 
Commission and be forwarded as a Commission proposal; where the imple-
mentation of such a directive would involve the amendment of legislation 
in ooe or more Member States, as this directive certainly would, the 
European Parliament would then be consulted once again on its own proposal. 
However, the Council could argue that further consultation was unnecessary; this 
would deprive the European Parliament the opportunity to modify its 
earlier views in the light of a change in circumstances or a long delay 
by either of the other institutions involved or of any textual changes effected 
by the Commission. Be that as it may, the question arises as to whether 
1oJ C 234, 14 September 1981, page 64. 
2Attached to Doe. 1-207/81: draftsman, Mr PROUT. 
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Parliamentary action of this type does not, save in very except1onal 
cases, give rise to more problems than it solves, and if it does not, 
rather than save time for the Commission, waste that of the Parliament. 
8. The proposal for a directive may also be premature, in so far as 
the earlier veterinary medicinal products directives have only come into 
force in the Member States a matter of months ago Con 9 October 1983>; 
the draft measure ~ppears to i'nore the obligations incumbent ~Y virtue of 
Article 23(2) of Directive 81/851/EE~ on the Commission to propose ''not 
later than 4 years after the entry into force of this Directive ••• all 
the appropriate measures for the abolititon of any remainin~ barriers to 
the free Movement of veterinary ~edical products'' and on the Council to 
"take a decision on the Commission proposal not later than one year atter 
its submission." 
9. Apart from the rbligations deriving from Article 23<2>, the 
Commission could also be given the opportunity to benefit from its exper-
ience of Directive 83/570/EEC2 which, as mentioned above (paragraph 4), 
extends and improves the market authorization system for proprietary 
medicinal products for human use. It might be that similar modifications 
could eventually be proposed to the procedures of the Committee on 
Veterinary Medical Products. In such a complex area of the approximation 
of the laws of the member States- it took the Council six years from the 
submission of the Commission's proposals to adopt the two existing 
directives - it might be neither reatistic nor necessarily desirabte for 
the Parliament to press for the Commission or Council to act with what 
could appear to be indecent haste. 
~0. The committe~howeve~ took the view that, in the matter of legis-
lative initiative,. the European Parliament should keep its options open: 
it was observed that Parliament had adopted a "proposal for a Council 
resolution" as part of its resolution of 19 January 1984 on the 
Communication from the Commission of the European Communities to the 
Council on"Energy and energy research in the Community: a five-year 
programme of action and its financing~ on the initiative of the Committee 
on Energy, Research and Technology. 
1 OJ L 317, 6 November 1981, page 1. 
2 OJ L 332, 28 November 1983, page 1. 
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11. The Legal Affairs Committee consi~ered that it would be possible for the 
Commission on Agriculture to produce a Council directive on the approximation 
of the laws of the Member States relating to the distribution of veterinary 
medicinal products. 
The Committee would wish to reserve its position on the details of 
any such legislation until such time as it is proposed by the Commission. 
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Letter from the Chairman of the Committee to Mr CURRY, Chairman of the Committee 
on Agriculture 
Subject: Own-initiative report on the liability of producers and distributors 
of veterinary pharmaceuticals 
Luxembourg, 7 February 1984 
Dear Mr Chairman, 
The Committee on the Environment, Public Health and Consumer Protection 
considered the above mentioned subject at its meeting of 3 F~bruary 1984. 
The Committee on the Environment, Public Health and Consumer Protection has 
come to the following conclusions: 
a> distribution of medicines with a withdrawal period for residues should be 
restricted to pharmacists and veterinary surgeons and the issue of a 
prescription should be compulsory. The prescription should indicate the 
withdrawal period when animals are treated; 
b) if after analysis the product is found to contain residues, it will be 
impounded, at the manufacturer's expense, if he cannot produce a prescription 
or has not respected the prescribed withdrawal periods. This is a highly 
educative measure, it would curb the inoppertune, ill-considered and 
clandestine use of medicines; 
c) the considerable pressure applied by those who manufacture, distribute 
or sell medicines through Legal, semi-legal or illegal channels makes it 
very difficult to apply controls at source, i.e. upstream. 
The important thing is to impose downstream controls, systematic analytical 
checks on products prior to sale with impounding of goods and fines for the 
manufacturer if the offence is repeated. 
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Please consider this Letter as the opinion of the Committee on the 
Environment, Public Health and Consumer Protection. 
Yours sincerely, 
(sgd).Kenneth 0. COLLINS 
Chairman 
The following took part in the vote: Or SHERLOCK, chairman; Mr ESTGEN 
(replacing Mr ALBER>; Mr GHERGO; Mrs LENTZ-CORNETTE; Mrs SCHLEICHER; 
Mrs SEIBEL-EMMERLING; Mrs SPAAK; Mrs SQUARCIALUPI. 
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